Periodontal Therapeutics Market

SKU: DMPH1888 | Last Updated On: Dec 01 2021 | No. of Pages: 180 | Available Formats

> Global Periodontal Therapeutics Market Expected to reach at a high CAGR of 8.8% by 2028: DataM Intelligence

Global Periodontal Therapeutics Market is segmented By Therapeutic Type (Systemic Antibiotics (Doxycycline, Minocycline, Metronidazole, and Others), Local Antibiotics (Arestin, Atridox, PerioChip, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The global periodontal therapeutics market size was worth US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028).

Periodontal disease, commonly known as gum disease, is where the periodontal tissues surrounding the teeth are in a pathological inflammatory condition. Periodontitis is relatively common, usually caused by poor oral hygiene, and can be prevented in most cases. Periodontitis can lead to tooth loss and is a risk factor for heart and lung diseases. Its symptoms include red swollen and tender gums. Periodontal therapeutics is the non-surgical treatment for periodontal diseases.

Source: DataM Intelligence Analysis (2021)

Market Dynamics

The global periodontal therapeuticsmarket growth is driven by therising prevalence of periodontal disease, robust pipeline drugs, surge in awareness about oral health.

Robust pipeline of drugsis expected to drive the growth in the forecast period

The periodontal therapeutics market is witnessing many clinical developments and product launches, thereby resulting in increased prescription and market demand. Large pharmaceutical companies and healthcare associations are focusing on advanced therapeutics for the non-surgical treatment of gum disease. The use of antibiotics, particularly systemic antibiotics, as first-line therapy in periodontitis is rapidly growing with the innovation of new products. These innovations are likely to cater to the unmet needs of periodontal disease patients globally.

Biological therapeutics is another key area of development in the periodontal therapeutics market. With increasing evidence towards the role of biologics in dental health, the focus is on promoting biologic agents for periodontal regeneration. For instance, Trafermin – a fiblast spray developed by Kaken Pharmaceutical, was approved to treat periodontitis in Japan in 2016.

Moreover, in 2017, Geistlich Pharma conducted Phase 2 clinical trials of PerioSept, a new experimental gel formulation. PerioSept is developed to be used as adjunctive therapy for periodontitis treatment. Also, in March 2021, Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel complement therapeutics, announced positive top-line Phase 2 results from its randomized, placebo-controlled clinical trial evaluating AMY-101 in 39 patients withperiodontal inflammation and gingivitis.

Use of alternative oral hygiene products is likely to hinder the market growth

While surgical interventions and non-surgical treatment has been the most widely used procedures of periodontal treatment globally, adjuvant therapies are still under nascent stage of application. Also, the oral health industry is rapidly transforming with oral hygiene products protruding in to the oral health spectrum. The development of toothpastes and gels are likely to lower the use of therapeutics. Furthermore, these non-prescription sold products are likely to improve the overall oral health of users, thereby reducing the risk of periodontal diseases, over the long run. Specially formulated toothpastes with functional claims towards healing bleeding gums, improving seal between teeth and gums and help with gingivitis are hitting the market. Mouth cleansers to help freshen breath and reduce mouth bacteria are another key product category attracting development towards oral health.

For instance, a germicidal mouthwash based on Chlorhexidine gluconate is widely prescribed by dentists to prevent or lower the risk of periodontal disease and as a post-treatment adjuvant.

COVID-19 Impact Analysis

The outbreak of COVID-19 has had a negative impact on the global periodontal therapeutics market. The sales growth of antibiotics for periodontal disease treatment were slightly declined in 2020 owing to reduced hospital visits for dental services and prescriptions from dentists globally. Healthcare facilities across the world faced unprecedented situation due to the rapid spread of novel coronavirus with overburdening diagnostics, in-patient care and post-recovery complexities. Most of the dental care services are considered ‘non-essential’ alike by population, dental providers and healthcare bodies in response to the pandemic. The Centers for Medicare & Medicaid Services (CMS) in March 2020 recommended dentalproviders in clinics and hospitals across the U.S. to limit non-essential dental, medical and surgical procedures to reduce the spread of virus and conserve medical PPEs. This has resulted in a significant drop in number of periodontal treatments including surgical and non-surgical. However, adjuvant therapies including the use of antibiotics is relatively resilient over surgical treatment procedures owing to over-the-counter sales.

Segment Analysis

Thechlorhexidinesegmentis expected to hold the largest share in this market segment

The main ingredient in most mouthwashes that are geared towards patients suffering from gum disease is chlorhexidine. The use of chlorhexidine mouthwashes is an excellent way to maintain and treat mild forms of gum disease. Bleeding gums treatment almost always includes the use of chlorhexidine mouthwash. Chlorhexidine gluconate is a prescription antiseptic used in dentistry to fight bacteria found in the oral cavity that contributes to gum disease. The most common form this antiseptic comes in is oral rinses, but it can also be available in gels or small chips inserted into the gingival sulcus. Chlorhexidine (marketed as the prescription-only brands Peridex, PerioChip, PerioGard, Denti-Rinse, Paroex, Acclean) is an antimicrobial used to control plaque and gingivitis in the mouth or periodontal pockets. For instance, Medicom, Denti-Care Denti-Rinse Chlorhexidine Oral Rinse Gluconate mint provides extra boost to reduce the tissue inflammation, bleeding and ideal for periodontitis, oral irrigation.

Source: DataM Intelligence Analysis (2021)

Geographical Analysis

North America region holds the largest market share of global periodontal therapeutics market

North America accounts for the most significant market share in the global market and is mainly attributed to the growing patient pool with periodontal diseases, increasing geriatric population and diabetic population in the region. Moreover, other factors increasing the regional market share are the rise in healthcare expenditure, advanced healthcare infrastructure, high level of drug development, presence of established market players, high investment in R&D activities by key players and presence of a proper regulatory framework for periodontal drugs. For instance, in February 2017, Oral Science launched Fluorimax, next-generation fluoride varnishes intended to treat dental caries. Also, in August 2021, NIH awarded a $2M grant to ADA Science & Research Institute, the University of Pennsylvania, to study oral mucosa. The American Dental Association Science & Research Institute, together with the University of Pennsylvania School of Dental Medicine, will evaluate the mechanisms that maintain and damage the barrier function of oral epithelium in the presence of periodontal disease and peri-implantitis.

 The United States is leading the North American periodontal therapeutics market. According to the CDC, periodontitis, a more severe form of periodontal disease, affects 50 percent of Americans aged 30 and up. It is around 64.7 million people in the United States. In addition, 64 percent of persons 65 and older in the study had moderate or severe periodontitis. This figure is significantly higher than prior national figures. The number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older will nearly quadruple between 2000 and 2040. Hence, with the growing aging population and an increasing number of patients with periodontal diseases, the market for periodontal therapeutics is expected to grow.

Source: DataM Intelligence Analysis (2021)

Competitive Landscape

The global Periodontal Therapeutics market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market includeKaken Pharmaceutical Co. Ltd, OraPharma Inc, Colgate-Palmolive, Xttrium Laboratories, Inc., Medicom, Pfizer Inc, 3M, Den-Mat Holdings LLC, Dexcel Pharma, Bausch Health (Valeant).The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the wound care management devices globally. For instance,In December 7, 2020, DenMat Holdings LLC had launched a new consumer website, OralProCare.com reportedly provides consumer access to several at-home oral health care products, including the Rotadent ProCare power toothbrush and Perio Restore oral cleansing gel.

Key Companies to Watch

Colgate-Palmolive

Overview:Colgate-Palmolive Company is a multinational consumer goods corporation based in the United States. It is a manufacturer, distributor, and provider of household, health care, personal care and veterinary products.Their oral care segment consists of brands like Colgate, Sorriso, Tom's of Maine, elmex and hello.Colgate is a well-known American brand that primarily manufactures oral hygiene goods such as toothpastes, toothbrushes, mouthwashes, and dental floss.Under the 'Colgate' brand, there are toothpastes, toothpowder toothbrushes, and mouthwashes, as well as a specialist variety of dental therapies under the umbrella of Colgate Oral Pharmaceuticals.

Product Portfolio: It includes products like PERIOGARD (CHLORHEXIDINE GLUCONATE) is an oral rinse intended for use between dental appointments as part of a professional treatment programme for gingivitis.

Key Developments:In January 23, 2020, Colgate-Palmolive Company acquired Hello Goods LLC. Hello distributes toothpaste, mouthwash, toothbrushes, dental floss, teething gel, and other items in retail locations, online, and by subscription in the United States. With this acquisition hello will be a fantastic compliment to Colgate and Tom's of Maine brands, with its distinct on-trend positioning, and will continue to add to its growth and success.

Why Purchase the Report?

  • Visualize the composition of the periodontal therapeutics market segmentation by drug type, distribution channel and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in periodontal therapeutics market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of periodontal therapeutics market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global periodontal therapeutics market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages. 

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Periodontal Therapeutics Market– By Drug Type

  • Doxycycline
  • Chlorhexidine
  • Minocycline
  • Metronidazole
  • Others

Global Periodontal Therapeutics Market – By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • Other Distribution Channels
    • Dental Office
    • Others

Global Periodontal Therapeutics Market - By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Trending Topics

Scleroderma Therapeutics Market

Xerostomia Therapeutics Market

​​​​​​

Table of Contents

  1. Global Periodontal Therapeutics Market -Scope and Methodology

    1. Research Methodology
    2. Scope of the market
  2. Global Periodontal Therapeutics Market -Key Trends and Developments

    1. Key Trends and Developments
  3. Global Periodontal Therapeutics Market – Executive Summary

    1. Market Snippet By Therapeutic Type
    2. Market Snippet By Distribution Channel
    3. Market Snippet By Region
    4. DataM CLO Scenario
  4. Global Periodontal Therapeutics Market Dynamics

    1. Market impacting factors
      1. Drivers
        1. Increasing prevalence of periodontal diseases
        2. Rise in number of diabetic patients and geriatric population
        3. Driver 3
      2. Restraints
        1. Lack of reimbursement policies
        2. Restraint 2
      3. Opportunity
    2. Impact analysis
  5. Global Periodontal Therapeutics Market – Industry Analysis

    1. Porter's five forces analysis
    2. Supply chain analysis
    3. Pricing analysis
    4. Regulatory analysis
    5. Patent analysis
  6. Global Periodontal Therapeutics Market – By Therapeutic Type

    1. Introduction
      1. Market size analysis, and y-o-y growth analysis (%), By Therapeutic Type segment
      2. Market attractiveness index, By Therapeutic Type segment
    2. Systemic Antibiotics         
      1. Introduction
      2. Market size analysis, and y-o-y growth analysis (%)
      3. Doxycycline
      4. Minocycline
      5. Metronidazole
      6. Others
    3. Local Antibiotics
      1. Arestin
      2. Atridox
      3. PerioChip
      4. Others
  7. Global Periodontal Therapeutics Market – By Distribution Channel

    1. Introduction
    2. Market size analysis, and y-o-y growth analysis (%), By  Distribution Channel segment
    3. Market attractiveness index, By  Distribution Channel segment
    4. Hospital Pharmacies         
      1. Introduction
      2. Market size analysis, y-o-y growth analysis (%)
    5. Retail Pharmacies 
    6. E-commerce           
  8. Global Periodontal Therapeutics Market – By Region

    1. Introduction
      1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key region-specific dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By  Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By  Distribution Channel
      5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Countries
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East And Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Therapeutic Type
      4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Distribution Channel
  9. Global Periodontal Therapeutics Market – Competitive Landscape

    1. Competitive scenario
    2. Competitor strategy analysis
    3. Comparative type portfolio analysis
    4. Market positioning/share analysis
    5. Mergers and acquisitions analysis
  10. Global Periodontal Therapeutics Market – Company Profiles

    1. 3M
      1. Company Overview
      2. Type Portfolio And Description
      3. Key Highlights
      4. Financial Overview
    2. Den-Mat Holdings, LLC
    3. Dexcel Pharma
    4. Valeant Pharmaceuticals International Inc.
    5. Kaken Pharmaceutical Co. Ltd.
    6. Galderma S.A.
    7. OraPharma Inc
    8. Dentsply International
  11. Global Periodontal Therapeutics Market – Premium Insights

  12. Global Periodontal Therapeutics Market – DataM

    1. Appendix
    2. About us and services
    3. Contact us

List of Tables & Figures

List of Tables

Table 1Global Periodontal Therapeutics Market Value, By Drug Type, 2020, 2024 & 2028 ($ Million)

Table 2Global Periodontal Therapeutics Market Value, By Distribution Channel, 2020, 2024 & 2028 ($ Million)

Table 3Global Periodontal Therapeutics Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 4Global Periodontal Therapeutics Market Value, By Drug Type, 2020, 2024 & 2028 ($ Million)

Table 5Global Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 6Global Periodontal Therapeutics Market Value, By Distribution Channel, 2020, 2024 & 2028 ($ Million)

Table 7Global Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 8Global Periodontal Therapeutics Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 9Global Periodontal Therapeutics Market Value, By Region, 2019-2028 ($ Million)

Table 10North America Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 11North America Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 12North America Periodontal Therapeutics Market Value, By Country, 2019-2028 ($ Million)

Table 13South America Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 14South America Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 15South America Periodontal Therapeutics Market Value, By Country, 2019-2028 ($ Million)

Table 16Europe Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 17Europe Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 18Europe Periodontal Therapeutics Market Value, By Country, 2019-2028 ($ Million)

Table 19Asia-Pacific Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 20Asia-Pacific Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 21Asia-Pacific Periodontal Therapeutics Market Value, By Country, 2019-2028 ($ Million)

Table 22Middle East & Africa Periodontal Therapeutics Market Value, By Drug Type, 2019-2028 ($ Million)

Table 23Middle East & Africa Periodontal Therapeutics Market Value, By Distribution Channel, 2019-2028 ($ Million)

Table 24Kaken Pharmaceutical Co. Ltd: Overview

Table 25Kaken Pharmaceutical Co. Ltd: Product Portfolio

Table 26Kaken Pharmaceutical Co. Ltd: Key Developments

Table 27OraPharma Inc: Overview

Table 28OraPharma Inc: Product Portfolio

Table 29OraPharma Inc: Key Developments

Table 30Xttrium Laboratories, Inc: Overview

Table 31Xttrium Laboratories, Inc: Product Portfolio

Table 32Xttrium Laboratories, Inc: Key Developments

Table 33Medicom, Pfizer Inc: Overview

Table 34Medicom, Pfizer Inc: Product Portfolio

Table 35Medicom, Pfizer Inc: Key Developments

Table 363M: Overview

Table 373M: Product Portfolio

Table 383M: Key Developments

Table 39Den-Mat Holdings LLC: Overview

Table 40Den-Mat Holdings LLC: Product Portfolio

Table 41Den-Mat Holdings LLC: Key Developments

Table 42Dexcel Pharma: Overview

Table 43Dexcel Pharma: Product Portfolio

Table 44Dexcel Pharma: Key Developments

Table 45Bausch Health (Valeant): Overview

Table 46Bausch Health (Valeant): Product Portfolio

Table 47Bausch Health (Valeant): Key Developments

Table 48Pfizer Inc: Overview

Table 49Pfizer Inc: Product Portfolio

Table 50Pfizer Inc: Key Developments

Table 51Colgate Palmolive: Overview

Table 52Colgate Palmolive: Product Portfolio

Table 53Colgate Palmolive: Key Developments

List of Figures

Figure 1Global Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 2Global Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 3Global Periodontal Therapeutics Market Share, By Region, 2020 & 2028 (%)

Figure 4Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 5Global Periodontal Therapeutics Market Y-o-Y Growth, By Drug Type, 2020-2028 (%)

Figure 6Doxycycline: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 7Chlorhexidine: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 8Minocycline: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 9Metronidazole: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 10Others: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 11Global Periodontal Therapeutics Market Y-o-Y Growth, By Distribution Channel, 2020-2028 (%)

Figure 12Hospital Pharmacies: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 13Retail Pharmacies: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 14E-commerce: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 15Other Distribution Channels: Global Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 16Global Periodontal Therapeutics Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure 17North America Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 18North America Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 19North America Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 20North America Periodontal Therapeutics Market Share, By Country, 2020 & 2028 (%)

Figure 21South America Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 22South America Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 23South America Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 24South America Periodontal Therapeutics Market Share, By Country, 2020 & 2028 (%)

Figure 25Europe Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 26Europe Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 27Europe Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 28Europe Periodontal Therapeutics Market Share, By Country, 2020 & 2028 (%)

Figure 29Asia-Pacific Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 30Asia-Pacific Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 31Asia-Pacific Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 32Asia-Pacific Periodontal Therapeutics Market Share, By Country, 2020 & 2028 (%)

Figure 33Middle East & Africa Periodontal Therapeutics Market Value, 2019-2028 ($ Million)

Figure 34Middle East & Africa Periodontal Therapeutics Market Share, By Drug Type, 2020 & 2028 (%)

Figure 35Middle East & Africa Periodontal Therapeutics Market Share, By Distribution Channel, 2020 & 2028 (%)

Figure 36Kaken Pharmaceutical Co. Ltd: Financials

Figure 37OraPharma Inc: Financials

Figure 38Xttrium Laboratories, Inc: Financials

Figure 39Medicom, Pfizer Inc: Financials

Figure 403M: Financials

Figure 41Den-Mat Holdings LLC: Financials

Figure 42Dexcel Pharma: Financials

Figure 43Bausch Health (Valeant): Financials

Figure 44Pfizer Inc: Financials

Figure 45Colgate Palmolive: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest